Why Valuation Matters Before You Raise Funding

One of the most important questions every deep-tech founder will eventually face is simple: what is the company actually worth? For biotech and deep-tech startups, this can be difficult to answer. Many companies are still pre-revenue and operate in highly technical sectors characterised by long development timelines, regulatory complexity, and significant capital requirements.

However, valuation plays a critical role in shaping investment discussions. It influences investor confidence, equity dilution, strategic partnerships, licensing negotiations, and future fundraising rounds. Without a structured valuation approach, startups often enter discussions without a clear understanding of their own commercial position.

At Maravion, we support startups through company valuation, financial modelling, market analysis, scenario planning, and investor readiness preparation. Our goal is to help founders translate complex science into credible, investable business opportunities supported by realistic commercial assumptions.

A strong valuation is not about inflating numbers or creating unrealistic expectations. It is about demonstrating a clear understanding of market opportunity, scalability, commercial risk, and long-term growth potential. In deep-tech sectors, investors are looking for businesses that understand both their science and their strategy